miR‐579‐3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3‐Kinase–Protein Kinase B Pathway in Chronically Inflamed Liver-Reference-Cited by-同舟云学术

miR‐579‐3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3‐Kinase–Protein Kinase B Pathway in Chronically Inflamed Liver

Published:2022-02-08 Issue:6 Volume:6 Page:1467-1481
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Quintavalle Cristina,Meyer‐Schaller Nathalie,Roessler Stephanie,Calabrese Diego,Marone Romina,Riedl Tobias,Picco‐Rey Silvia,Panagiotou Orestis A.,Uzun Sarp,Piscuoglio Salvatore,Boldanova Tuyana,Bian Chaoran B.,Semela David,Jochum Wolfram,Cathomas Gieri,Mertz Kirsten D.,Diebold Joachim,Mazzucchelli Luca,Koelzer Viktor H.,Weber Achim,Decaens Thomas,Terracciano Luigi M.,Heikenwalder Mathias,Hoshida Yujin,Andersen Jesper B.,Thorgeirsson Snorri S.,Matter Matthias S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1894

Reference36 articles.

1. Future of hepatocellular carcinoma incidence in the United States forecast through 2030;J Clin Oncol,2016

2. Global cancer incidence and mortality rates and trends–an update;Cancer Epidemiol Biomarkers Prev,2016

3. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;CA Cancer J Clin,2021

4. Liver inflammation and hepatobiliary cancers;Trends Cancer,2021

5. Hepatocellular carcinoma;Nat Rev Dis Primers,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p;Cell Death Discovery;2024-03-14

2. The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors;Cell Death & Disease;2024-03-12

3. Withaferin A suppressed hepatocellular carcinoma progression through inducing IGF2BP3/FOXO1/JAK2/STAT3 pathway-mediated ROS production;Immunopharmacology and Immunotoxicology;2023-09-06

4. Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion;Biomedicines;2023-06-19

5. Tumor heterogeneity: preclinical models, emerging technologies, and future applications;Frontiers in Oncology;2023-04-28